Prothena | PRTA - EPS Earnings Per Share


Prothena reported $0.6 in EPS Earnings Per Share for its fiscal quarter ending in March of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2027Q1 Mar/2026 0.60 -0.35 -1.12 May/07




Eps Change Date
Acadia Pharmaceuticals USD 0.02 1.58 Mar/2026
Agios Pharmaceuticals USD -1.69 0.17 Mar/2026
Akebia Therapeutics USD -0.04 0.04 Dec/2025
ALKERMES USD -0.4 0.69 Mar/2026
Alnylam Pharmaceuticals USD 1.99 0.74 Mar/2026
Amgen USD 5.15 0.14 Mar/2026
Biogen USD 3.57 1.58 Mar/2026
BioMarin Pharmaceutical USD 0.76 0.3 Mar/2026
Exelixis USD 0.87 0.1 Mar/2026
Immunic USD -0.1 0.03 Dec/2025
Incyte USD 1.81 0.01 Mar/2026
Ionis Pharmaceuticals USD -0.56 0.85 Mar/2026
MacroGenics USD -0.58 0.36 Mar/2026
Nektar Therapeutics USD -1.35 1.17 Dec/2025
Neurocrine Biosciences USD 1.94 0.06 Mar/2026
Prothena USD 0.6 1.06 Mar/2026
Regeneron Pharmaceuticals USD 9.47 1.97 Mar/2026
Ultragenyx Pharmaceutical USD -1.84 0.55 Mar/2026
Vertex Pharmaceuticals USD 4.47 0.56 Mar/2026
Xoma USD -1.59 2.43 Sep/2024